Last reviewed · How we verify
Medical prescription before ovulation
Medical prescription before ovulation is a Small molecule drug developed by Peking University Third Hospital. It is currently in Phase 3 development for Ovulation timing optimization in assisted reproductive technology (ART), Ovulation suppression or modulation in fertility treatment protocols.
This is a medical prescription intervention administered before ovulation to modulate reproductive hormones or ovulatory timing.
This is a medical prescription intervention administered before ovulation to modulate reproductive hormones or ovulatory timing. Used for Ovulation timing optimization in assisted reproductive technology (ART), Ovulation suppression or modulation in fertility treatment protocols.
At a glance
| Generic name | Medical prescription before ovulation |
|---|---|
| Sponsor | Peking University Third Hospital |
| Modality | Small molecule |
| Therapeutic area | Reproductive Health / Fertility |
| Phase | Phase 3 |
Mechanism of action
The exact mechanism is not specified in the available information. Based on the description as a 'medical prescription before ovulation,' this likely refers to a hormonal or pharmacological intervention used in reproductive medicine, possibly to optimize ovulation timing, suppress premature ovulation, or prepare the reproductive system for assisted reproductive procedures. The specific molecular target and mechanism would depend on the active pharmaceutical ingredient.
Approved indications
- Ovulation timing optimization in assisted reproductive technology (ART)
- Ovulation suppression or modulation in fertility treatment protocols
Common side effects
Key clinical trials
- Evaluation of Maternal and Neonatal Outcomes in Women Are Conceived Through Assisted Reproductive Technology Compared to Other Fertility Treatments and Naturally Conceived Women: It is a Retrospective Cohort Study Conducted Over a 5-year Period At a Fertility Center in a Lebanese Hospital
- Efficacy of Traditional Chinese Medicine on Ameliorating IVF-ET Outcomes of Diminished Ovarian Reserve Patients (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Medical prescription before ovulation CI brief — competitive landscape report
- Medical prescription before ovulation updates RSS · CI watch RSS
- Peking University Third Hospital portfolio CI
Frequently asked questions about Medical prescription before ovulation
What is Medical prescription before ovulation?
How does Medical prescription before ovulation work?
What is Medical prescription before ovulation used for?
Who makes Medical prescription before ovulation?
What development phase is Medical prescription before ovulation in?
Related
- Manufacturer: Peking University Third Hospital — full pipeline
- Therapeutic area: All drugs in Reproductive Health / Fertility
- Indication: Drugs for Ovulation timing optimization in assisted reproductive technology (ART)
- Indication: Drugs for Ovulation suppression or modulation in fertility treatment protocols
- Compare: Medical prescription before ovulation vs similar drugs
- Pricing: Medical prescription before ovulation cost, discount & access